DAINIP S'TOMO PHARM

BE:DPM Germany Other
Market Cap
$121.82K
€118.67K EUR
Market Cap Rank
#40511 Global
#5967 in Germany
Share Price
€12.50
Change (1 day)
+1.63%
52-Week Range
€2.94 - €14.90
All Time High
€28.22
About

There is no Profile data available for DPM.BE.

DAINIP S'TOMO PHARM (DPM) - Total Liabilities

Latest total liabilities as of March 2025: €573.12 Billion EUR

Based on the latest financial reports, DAINIP S'TOMO PHARM (DPM) has total liabilities worth €573.12 Billion EUR as of March 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

DAINIP S'TOMO PHARM - Total Liabilities Trend (2017–2025)

This chart illustrates how DAINIP S'TOMO PHARM's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

DAINIP S'TOMO PHARM Competitors by Total Liabilities

The table below lists competitors of DAINIP S'TOMO PHARM ranked by their total liabilities.

Company Country Total Liabilities
Essex Minerals Inc
PINK:ESXMF
USA $1.08 Million
NEOPOST - Dusseldorf Stock Exchang
DU:NEQ
Germany €1.48 Billion
RTX (RTE.SG)
STU:RTE
Germany €167.51 Million

Liability Composition Analysis (2017–2025)

This chart breaks down DAINIP S'TOMO PHARM's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.05 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 3.38 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.77 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how DAINIP S'TOMO PHARM's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for DAINIP S'TOMO PHARM (2017–2025)

The table below shows the annual total liabilities of DAINIP S'TOMO PHARM from 2017 to 2025.

Year Total Liabilities Change
2025-03-31 €573.12 Billion -23.72%
2024-03-31 €751.37 Billion +3.22%
2023-03-31 €727.96 Billion +14.74%
2022-03-31 €634.44 Billion -3.87%
2021-03-31 €659.95 Billion +6.31%
2020-03-31 €620.77 Billion +84.44%
2019-03-31 €336.58 Billion -5.71%
2018-03-31 €356.96 Billion +7.10%
2017-03-31 €333.29 Billion --